E. Scheibel

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.

Bray Gl, Gomperts Ed, S Courter et al. · PubMed · 1994 · 353 citations

Medicine, Hematology, Pharmacotherapy +17

Clinical course of primary HIV infection: consequences for subsequent course of infection.

C. Pedersen, Bjarne Ørskov Lindhardt, B L Jensen et al. · BMJ · 1989 · 187 citations · Full text

Life Sciences, Clinical Sciences, Infectious Diseases +12

A Multicenter Study of Recombinant Factor VIII (Recombinate): Safety, Efficacy, and Inhibitor Risk in Previously Untreated Patients With Hemophilia A

Gordon L. Bray, Edward D. Gomperts, S. Courier et al. · Blood · 1994 · 165 citations

Medicine, Hematology, Pharmacotherapy +17

Major Surgery in Haemophilic Patients with Inhibitors Using Recombinant Factor VIla

J. Ingerslev, D. Freidman, D A Gastineau et al. · Haemostasis · 2009 · 120 citations

Medicine, Hematology, Surgery +17

Can long‐term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands

Karin van Dijk, Kathelijn Fischer, Johanna G. van der Bom et al. · British Journal of Haematology · 2005 · 91 citations · Full text

Medicine, Hematology, Pediatrics +10